Neuroprotection in MS

Multiple sclerosis (MS) is the most common chronic inflammatory disease of the central nervous system which is characterized by inflammatory demyelination and neurodegeneration. Here is the latest research on neuroprotective mechanisms in MS.

August 31, 2020
Open Access

Isomeric O-methyl cannabidiolquinones with dual BACH1/NRF2 activity

Redox Biology
Laura CasaresLaureano de la Vega
August 7, 2020
Review
Open Access

Exploring the Use of Dimethyl Fumarate as Microglia Modulator for Neurodegenerative Diseases Treatment

Antioxidants
Maria RositoSilvia Di Angelantonio
May 30, 2020
Comment / Editorial
Open Access

MS-SMART study: systematic sampling bias concerns - Authors' reply

Lancet Neurology
Jeremy ChatawayMS-SMART Investigators
June 27, 2020

Prevalence of disability improvement as a potential outcome for multiple sclerosis trials

Multiple Sclerosis : Clinical and Laboratory Research
Alessio SignoriMaria Pia Sormani
August 22, 2020
Review

Effects of dietary restriction on gut microbiota and CNS autoimmunity

Clinical Immunology : the Official Journal of the Clinical Immunology Society
Claudia CantoniLaura Piccio
September 19, 2020

Lithium Use During Pregnancy in a Patient With Bipolar Disorder and Multiple Sclerosis

Clinical Neuropharmacology
Liliana LorettuLiliana DellʼOsso
September 6, 2020
Open Access

Changes of central noradrenaline transporter availability in immunotherapy-naïve multiple sclerosis patients

Scientific Reports
Elisa SchmidtFlorian Then Bergh
August 5, 2020
Review

The molecular anatomy and functions of the choroid plexus in healthy and diseased brain

Biochimica Et Biophysica Acta. Biomembranes
Ingrid KratzerHelen Stolp
September 19, 2020
Preprint
Open Access

Demyelination induces selective vulnerability of inhibitory networks in multiple sclerosis

BioRxiv : the Preprint Server for Biology
L. ZoupiAnna Williams
June 13, 2020
Review
Open Access

In vitro Models of Neurodegenerative Diseases

Frontiers in Cell and Developmental Biology
Anna SlanziGabriela Constantin
September 2, 2020
Review
Open Access

Age-Related Changes and Sex-Related Differences in Brain Iron Metabolism

Nutrients
Tanja Grubić Kezele, Božena Ćurko-Cofek
July 17, 2020
Open Access

High-dose vitamin B supplementation for persistent visual deficit in multiple sclerosis: a pilot study

Drug Discoveries & Therapeutics
Fabiana MalloneAntonietta Moramarco
September 3, 2020
Preprint
Open Access

Microglia-neuron communication at nodes of Ranvier depends on neuronal activity through potassium release and contributes to myelin repair.

BioRxiv : the Preprint Server for Biology
R. RonzanoAnne Desmazieres
June 7, 2020

Standard Operating Procedure for the Good Manufacturing Practice-Compliant Production of Human Endometrial Stem Cells for Multiple Sclerosis

Methods in Molecular Biology
Somayeh Ebrahimi-BaroughBabak Arjmand
August 5, 2020

Using Sigma-ligands as part of a multi-receptor approach to target diseases of the brain

Expert Opinion on Therapeutic Targets
James Michael BrimsonTewin Tencomnao

Sign up to follow this feed and discover related papers.

Related Feeds

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

Acute Disseminated Encephalomyelitis

Acute disseminated encephalomyelitis (ADEM) is a rare inflammatory demyelinating disease of the central nervous system. Discover the latest research on acute disseminated encephalomyelitis here.

© 2020 Meta ULC. All rights reserved
/feed-previews/neuroprotection-in-ms/86523020-c073-4107-9feb-9dd433c8d94e